Physician profile
Robert P Rose
NPI 1750347167
$3,419.18
in general payments reported to CMS, 2019-2025
20 companies · $20.70 in 2025
The $20.70 reported for 2025 was less than what a typical Gastroenterology (Internal Medicine) provider received nationally (typical 2025 total: $636).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,103 · 2020: $558 · 2021: $698 · 2022: $1,039 · 2025: $20.70.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $20.70.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $20.70 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,032.33 | 2019-2022 | |
| Takeda Pharmaceuticals U.S.A., INC. | $644.93 | 2019-2022 | |
| Janssen Biotech, INC. | $382.58 | 2019-2022 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $306.17 | 2019-2022 | |
| Pfizer INC. | $293.49 | 2019-2021 | |
| Medtronic, INC. | $169.96 | 2022 | |
| Gilead Sciences, INC. | $119.07 | 2019-2022 | |
| Nestle Healthcare Nutrition INC. | $98.13 | 2021-2022 | |
| Regeneron Healthcare Solutions, INC. | $78.79 | 2022 | |
| Merck Sharp & Dohme LLC | $48.90 | 2019 | |
| Ironwood Pharmaceuticals, INC | $40.06 | 2019-2020 | |
| Shionogi INC | $34.42 | 2019 | |
| Ardelyx, INC. | $34.31 | 2022 | |
| Ferring Pharmaceuticals INC. | $29.84 | 2021-2022 | |
| Qol Medical, LLC | $28.42 | 2021-2022 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ethicon US, LLC | $20.70 | 2025 | Vistaseal, Surgiflo Hemostatic Matrix |
| Axonics, INC. | $17.24 | 2022 | |
| Redhill Biopharma INC. | $16.06 | 2020 | |
| Ucb, INC. | $12.78 | 2020 | |
| Allergan, INC. | $11.00 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert Rose listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.